期刊文献+

脂肪肝纤维化评分系统在非酒精性脂肪性肝病人群高风险冠状动脉斑块预测中的价值 被引量:5

NAFLD fibrosis score is associated with high-risk coronary plaque in patients with NAFLD
原文传递
导出
摘要 目的探讨脂肪肝纤维化评分(NFS)系统在非酒精性脂肪性肝病(NAFLD)患者高风险冠状动脉斑块的预测价值。方法回顾性分析2012年1月至2017年12月期间的447名体检者。通过彩超检查诊断脂肪肝;通过计算NFS评价体检者的肝脏纤维化风险;利用冠状动脉计算机断层血管造影评估冠状动脉狭窄程度和高风险斑块。结果223名体检者(46.8%)患有NAFLD。在NAFLD组人群中,中-高NFS组比低NFS组更易出现高风险冠状动脉斑块(62.5%比24.0%)(P<0.001),NFS的最高四分位数(区间4)相比最低四分位数(区间1),高风险冠状动脉斑块风险增加2.24倍(P=0.016);在非NAFLD人群中,NFS和冠状动脉高风险斑块之间无显著关联(P>0.05)。在NAFLD组中,NFS可增加传统心血管疾病风险模型的预测水平,模型曲线下面积由0.679增至0.739(P=0.031);在非NAFLD组中,NFS对传统心血管风险预测模型无改善作用(有、无NFS的模型曲线下面积分别为0.766与0.764,P=0.715)。结论NFS可作为NAFLD患者冠状动脉斑块风险的预测指标。 Objective To investigate the possible role of non-invasive fibrosis scoring systems for detecting high-risk plaque among patients with non-alcoholic fatty liver disease(NAFLD).Methods A total of 477 consecutive asymptomatic subjects underwent a health checkup including coronary computed tomography angiography(CTA)and abdominal ultrasonography.Fatty liver was evaluated using ultrasonography,and the NAFLD fibrosis score(NFS)was calculated.Coronary stenosis and plaque were evaluated using coronary CTA.Results Of the study population,223 had NAFLD.Among the NAFLD patients,high-risk coronary plaque was more frequent in patients with high or intermediate NFS than those with low NFS(62.5%versus 24.0%,P<0.001).The adjusted odds ratio with 95%confidence interval of high-risk plaque was 3.24(1.11-9.40)for the highest versus lowest quartile of NFS(P=0.016).Among those without NAFLD,NFS was not associated with high-risk coronary plaque(C-statistic with NFS versus without NFS,0.766 versus 0.764,P=0.715).Adding NFS to the traditional cardiovascular disease(CVD)risk model increased the C-statistics by 0.679 to 0.739(P=0.031).Conclusions There was an independent association of NFS with high-risk coronary plaque in patients with NAFLD,suggesting its potential use to optimize management of patients with NAFLD.
作者 蔺红梅 汪丽清 全力 林妙霞 覃杰 余超 Lin Hongmei;Wang Liqing;Quan Li;Lin Miaoxia;Qin Jie;Yu Chao(Medical Examination Center,Third Affiliated Hospital,Sun Yat-sen University,Guangzhou 510630,China;Department of Neurology,Third Affiliated Hospital,Sun Yat-sen University,Guangzhou 510630,China;Department of Radiology,Third Affiliated Hospital,Sun Yat-sen University,Guangzhou 510630,China)
出处 《中华健康管理学杂志》 CAS CSCD 2022年第2期105-110,共6页 Chinese Journal of Health Management
基金 中国广东省科学技术计划项目基金(2009B03081008E) 高校基本科研业务费中山大学青年教师培育项目(20ykpy39)。
关键词 动脉粥样硬化 冠状动脉疾病 非酒精性脂肪性肝病 脂肪肝纤维化评分 Atherosclerosis Coronary artery disease Non-alcoholic fatty liver disease Non-invasive fibrosis score
  • 相关文献

参考文献3

二级参考文献53

  • 1Nobili V, Alkhouri N, Alisi A, Della Corte C, Fitzpatrick E, RaponiM, Dhawan A. Nonalcoholic fatty liver disease: a challenge for pediatricians. JAMA Pediatr 2015; 169: 170-176 [PMID: 25506780DOI: 10.1001/jamapediatrics.2014.2702].
  • 2Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, ContrerasM, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liverdisease and nonalcoholic steatohepatitis among a largely middleagedpopulation utilizing ultrasound and liver biopsy: a prospectivestudy. Gastroenterology 2011; 140: 124-131 [PMID: 20858492DOI: 10.1053/j.gastro.2010.09.038].
  • 3Anstee QM, Targher G, Day CP. Progression of NAFLD todiabetes mellitus, cardiovascular disease or cirrhosis. Nat RevGastroenterol Hepatol 2013; 10: 330-344 [PMID: 23507799 DOI:10.1038/nrgastro.2013.41].
  • 4Vernon G, Baranova A, Younossi ZM. Systematic review: theepidemiology and natural history of non-alcoholic fatty liver diseaseand non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther2011; 34: 274-285 [PMID: 21623852 DOI: 10.1111/j.1365-2036.2011.04724.x].
  • 5Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histologyin obese patients undergoing bariatric surgery. J Hepatol 2006; 45:600-606 [PMID: 16899321].
  • 6Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E,Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and itsconnection with insulin resistance, dyslipidemia, atherosclerosisand coronary heart disease. Nutrients 2013; 5: 1544-1560 [PMID:23666091 DOI: 10.3390/nu5051544].
  • 7Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA,Younossi ZM, Ahmed A. Nonalcoholic steatohepatitis is the secondleading etiology of liver disease among adults awaiting livertransplantation in the United States. Gastroenterology 2015; 148:547-555 [PMID: 25461851 DOI: 10.1053/j.gastro.2014.11.039].
  • 8Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, HuiJM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, WeltmanM, George J. NASH and insulin resistance: Insulin hypersecretionand specific association with the insulin resistance syndrome.Hepatology 2002; 35: 373-379 [PMID: 11826411].
  • 9Oni ET, Agatston AS, Blaha MJ, Fialkow J, Cury R, Sposito A,Erbel R, Blankstein R, Feldman T, Al-Mallah MH, Santos RD,Budoff MJ, Nasir K. A systematic review: burden and severity ofsubclinical cardiovascular disease among those with nonalcoholicfatty liver; should we care- Atherosclerosis 2013; 230: 258-267[PMID: 24075754 DOI: 10.1016/j.atherosclerosis.2013.07.052].
  • 10Than NN, Newsome PN. A concise review of non-alcoholicfatty liver disease. Atherosclerosis 2015; 239: 192-202 [PMID:25617860 DOI: 10.1016/j.atherosclerosis.2015.01.001].

共引文献1895

同被引文献65

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部